Inventor · disambiguated record
Frank Osterkamp
Also filed as: OSTERKAMP FRANK
23 granted patents·10 pending applications·77 citations·filing 2002–2022
94Inventor score
Top patents by PatentIndex Score
33 records- 0196US10800816B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2017·Granted Oct 13, 2020·10 cites·25 claims
- 0294US8450275B2TFPI inhibitors and methods of useDOCKAL MICHAEL·Filed 2011·Granted May 28, 2013·13 cites·31 claims
- 0393US10201586B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2016·Granted Feb 12, 2019·10 cites·17 claims
- 0481US9745344B2NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2015·Granted Aug 29, 2017·3 cites·8 claims
- 0581US9018167B2TFPI inhibitors and methods of useBAXTER INT·Filed 2013·Granted Apr 28, 2015·3 cites·16 claims
- 0680US10961199B2Neurotensin receptor ligands3B PHARMACEUTICALS GMBH·Filed 2013·Granted Mar 30, 2021·3 cites·26 claims
- 0780US9169293B2NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2013·Granted Oct 27, 2015·4 cites·19 claims
- 0880US8546523B2NPR-B agonistsOSTERKAMP FRANK·Filed 2010·Granted Oct 1, 2013·7 cites·3 claims
- 0979US10799605B2Conjugate comprising a neurotensin receptor ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2015·Granted Oct 13, 2020·3 cites·36 claims
- 1079US9458198B1Cyclic peptide-based NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2013·Granted Oct 4, 2016·2 cites·20 claims
- 1179US9447147B2Peptides and methods of useBAXTER INT·Filed 2015·Granted Sep 20, 2016·3 cites·9 claims
- 1278US8962563B2TFPI inhibitors and methods of useBAXTER INT·Filed 2013·Granted Feb 24, 2015·3 cites·21 claims
- 1376US9556230B2TFPI inhibitors and methods of useBAXTER INT·Filed 2015·Granted Jan 31, 2017·1 cites·10 claims
- 1474US11793855B2TFPI inhibitors and methods of useTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 24, 2023·0 cites·22 claims
- 1574US9982016B2NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2017·Granted May 29, 2018·1 cites·10 claims
- 1674US8029979B2Method for determining the substrate specificity of an enzymeJPT PEPTIDE TECHNOLOGIES GMBH·Filed 2006·Granted Oct 4, 2011·5 cites·14 claims
- 1772US9873720B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2014·Granted Jan 23, 2018·1 cites·4 claims
- 1869US8927534B2Compounds for the inhibition of integrins and use thereofZISCHINSKY GUNTHER·Filed 2007·Granted Jan 6, 2015·3 cites·4 claims
- 1967US8309735B2Heterocyclic compounds for the inhibition of integrins and use thereofZISCHINSKY GUNTHER·Filed 2007·Granted Nov 13, 2012·2 cites·74 claims
- 2062US10196423B2NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2018·Granted Feb 5, 2019·0 cites·3 claims
- 2160US2021087149A1Neurotensin receptor ligands3B PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 2256US12427210B2Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2020·Granted Sep 30, 2025·0 cites·55 claims
- 2354US2025296971A1Gastric inhibitory peptide receptor ligands3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 2454US2024115745A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 2554US2025339569A1Carbonic anhydrase ix ligands3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 2651US2024335569A1Fibroblast activation protein inhibitors and use thereof3 B Pharmaceuticals GmbH·Filed 2022·Application pending·0 cites
- 2750US2011065760A1Compounds for the inhibition of rotamases and use thereofJERINI AG·Filed 2009·Application pending·0 cites
- 2850US2023212549A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 2946US2004171097A1Method for determining the substrate specificity of an enzymatic activity and a device thereforFiled 2002·Application pending·0 cites
- 3045US10124033B2Peptides and methods of useBAXALTA INC·Filed 2016·Granted Nov 13, 2018·0 cites·19 claims
- 3144US2022315554A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 3239US2007054904A1Phenol derivatives and their use as rotamase inhibitorsJERINI AG·Filed 2003·Application pending·0 cites
- 3333US8501787B2Compounds for the inhibition of angiogenesis and use thereofZAHN GRIT·Filed 2005·Granted Aug 6, 2013·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Frank Osterkamp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →